-

Winning Pharma Companies Encourage a Culture of ‘Compliant Collaboration’ Between Commercial and Medical Affairs Teams

Only 39 Percent of Commercial Leaders Report a Strong to Very Strong Relationship with Medical Affairs Team, According to a New TGaS Landscape Report from Trinity Life Sciences

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, published its newest TGaS report entitled, Commercial/Medical Partnership Landscape: Driving Improvements in Communications, Coordination and Effectiveness. The report finds that pharmaceutical companies that encourage a culture of ‘compliant collaboration’ between Commercial and Medical Affairs teams ensures strong alignment that is critical to a product’s success.

“Often times within pharma, the Commercial and Medical Affairs teams are truly a tale of two cultures – each with their own specific backgrounds and agendas. Companies with strong Commercial/Medical Affairs relationships have an underlying philosophy to work with a ‘compliant collaboration’ mindset,” said Chris Welsh, Vice President, TGaS Advisors, a Division of Trinity. “This philosophy should begin at the C-suite level and permeate throughout the organization.”

While 53 percent of Medical Affairs leaders report they have an overall strong to very strong working relationship with Commercial leaders, only 39 percent of Commercial leaders report a strong to very strong relationship with Medical Affairs teams. Besides the key findings that the survey uncovers, the report also offers insights and actions pharma companies should take to strengthen the relationships between their Commercial and Medical Affairs teams.

The Landscape report is based on the responses of 20 Commercial leaders and 15 Medical Affairs leaders representing 32 separate biopharmaceutical companies. Members of the media can request a copy of the report by contacting Elizabeth Marshall at emarshall@trinitylifesciences.com.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom